Skip to main content
Top
Published in: European Radiology 5/2020

01-05-2020 | Magnetic Resonance Imaging | Hepatobiliary-Pancreas

Ancillary features in the Liver Imaging Reporting and Data System: how to improve diagnosis of hepatocellular carcinoma ≤ 3 cm on magnetic resonance imaging

Authors: Ji Hun Kang, Sang Hyun Choi, Jae Ho Byun, Dong Hwan Kim, So Jung Lee, So Yeon Kim, Hyung Jin Won, Yong Moon Shin, Pyo-Nyun Kim

Published in: European Radiology | Issue 5/2020

Login to get access

Abstract

Objectives

To determine the strength of association with hepatocellular carcinoma (HCC) of each ancillary feature (AF) in LI-RADS version 2018, and to develop an appropriate strategy for applying AFs to improve the diagnosis of HCC ≤ 3 cm on gadoxetate-enhanced MRI.

Methods

A total of 385 nodules (283 HCCs, 18 non-HCC malignancies, 84 benign nodules) of ≤ 3 cm in 266 patients at risk for HCC who underwent gadoxetate-enhanced MRI in 2016 were retrospectively evaluated. Two radiologists independently evaluated the presence/absence of AFs, and assigned a LI-RADS category to each nodule. Diagnostic odds ratio (DOR) of each AF was assessed. To improve the diagnostic performance for HCC, various criteria were developed based on the number of AFs favoring malignancy in general or HCC in particular. Generalized estimating equation models were used to compare the diagnostic performance of each criterion with that of the major features (MFs) only.

Result

All AFs favoring HCC in particular and malignancy in general were more common in the HCC group than in the non-HCC group. Of these AFs, hepatobiliary-phase hypointensity had the strongest association with HCC (DOR, 21.82; 95% confidence interval, 5.59–85.20). When we applied AFs in addition to MFs, the new criterion (with a number of AFs ≥ 4) had significantly higher sensitivity (80.6% vs. 70.0%; p < 0.001) than MFs only, without significant lower specificity (85.3% vs. 90.2%; p = 0.060).

Conclusions

The AFs varied in the strengths of association with HCC. More strict application of AFs (AFs ≥ 4) in LR-3 may improve the diagnostic performance for probable HCC ≤ 3 cm.

Key Points

The ancillary features (AFs) in the Liver Imaging Reporting and Data System version 2018 showed variable frequencies of occurrence and strengths of association with hepatocellular carcinoma (HCC).
• Of the various AFs, hepatobiliary-phase hypointensity had the highest frequency and strongest association with HCC on gadoxetate disodium–enhanced MRI.
• When applying AFs in addition to major features, a criterion of four or more AFs significantly increased the sensitivity for diagnosing HCC, without a significantly decreased specificity, especially in LR-3 observations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mitchell DG, Bruix J, Sherman M, Sirlin CB (2015) LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology 61:1056–1065CrossRef Mitchell DG, Bruix J, Sherman M, Sirlin CB (2015) LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology 61:1056–1065CrossRef
3.
go back to reference Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723–750CrossRef Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723–750CrossRef
4.
go back to reference Tang A, Bashir MR, Corwin MT et al (2018) Evidence supporting LI-RADS major features for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: a systematic review. Radiology 286:29–48CrossRef Tang A, Bashir MR, Corwin MT et al (2018) Evidence supporting LI-RADS major features for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: a systematic review. Radiology 286:29–48CrossRef
5.
go back to reference Cerny M, Bergeron C, Billiard JS et al (2018) LI-RADS for MR imaging diagnosis of hepatocellular carcinoma: performance of major and ancillary features. Radiology 288:118–128CrossRef Cerny M, Bergeron C, Billiard JS et al (2018) LI-RADS for MR imaging diagnosis of hepatocellular carcinoma: performance of major and ancillary features. Radiology 288:118–128CrossRef
6.
go back to reference Chernyak V, Tang A, Flusberg M et al (2018) LI-RADS® ancillary features on CT and MRI. Abdom Radiol (NY) 43:82–100CrossRef Chernyak V, Tang A, Flusberg M et al (2018) LI-RADS® ancillary features on CT and MRI. Abdom Radiol (NY) 43:82–100CrossRef
7.
go back to reference Choi SH, Byun JH, Kim SY et al (2016) Liver Imaging Reporting and Data System v2014 with gadoxetate disodium-enhanced magnetic resonance imaging: validation of LI-RADS category 4 and 5 criteria. Invest Radiol 51:483–490CrossRef Choi SH, Byun JH, Kim SY et al (2016) Liver Imaging Reporting and Data System v2014 with gadoxetate disodium-enhanced magnetic resonance imaging: validation of LI-RADS category 4 and 5 criteria. Invest Radiol 51:483–490CrossRef
8.
go back to reference Choi SH, Byun JH, Lim YS et al (2018) Liver Imaging Reporting and Data System: patient outcomes for category 4 and 5 nodules. Radiology 287:515–524CrossRef Choi SH, Byun JH, Lim YS et al (2018) Liver Imaging Reporting and Data System: patient outcomes for category 4 and 5 nodules. Radiology 287:515–524CrossRef
9.
go back to reference Joo I, Lee JM, Lee DH, Ahn SJ, Lee ES, Han JK (2017) Liver Imaging Reporting and Data System v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: comparison with multiphasic multidetector computed tomography. J Magn Reson Imaging 45:731–740CrossRef Joo I, Lee JM, Lee DH, Ahn SJ, Lee ES, Han JK (2017) Liver Imaging Reporting and Data System v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: comparison with multiphasic multidetector computed tomography. J Magn Reson Imaging 45:731–740CrossRef
10.
go back to reference Bland JM (2004) Cluster randomised trials in the medical literature: two bibliometric surveys. BMC Med Res Methodol 4:21CrossRef Bland JM (2004) Cluster randomised trials in the medical literature: two bibliometric surveys. BMC Med Res Methodol 4:21CrossRef
11.
go back to reference Feinstein AR, Cicchetti DV (1990) High agreement but low kappa: I. the problems of two paradoxes. J Clin Epidemiol 43:543–549CrossRef Feinstein AR, Cicchetti DV (1990) High agreement but low kappa: I. the problems of two paradoxes. J Clin Epidemiol 43:543–549CrossRef
12.
go back to reference Fraum TJ, Tsai R, Rohe E et al (2018) Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: diagnostic performance of the Liver Imaging Reporting and Data System version 2014. Radiology 286:158–172CrossRef Fraum TJ, Tsai R, Rohe E et al (2018) Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: diagnostic performance of the Liver Imaging Reporting and Data System version 2014. Radiology 286:158–172CrossRef
13.
go back to reference Cortis K, Liotta R, Miraglia R, Caruso S, Tuzzolino F, Luca A (2016) Incorporating the hepatobiliary phase of gadobenate dimeglumine-enhanced MRI in the diagnosis of hepatocellular carcinoma: increasing the sensitivity without compromising specificity. Acta Radiol 57:923–931CrossRef Cortis K, Liotta R, Miraglia R, Caruso S, Tuzzolino F, Luca A (2016) Incorporating the hepatobiliary phase of gadobenate dimeglumine-enhanced MRI in the diagnosis of hepatocellular carcinoma: increasing the sensitivity without compromising specificity. Acta Radiol 57:923–931CrossRef
14.
go back to reference Lee MH, Kim SH, Park MJ, Park CK, Rhim H (2011) Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. AJR Am J Roentgenol 197:W868–W875CrossRef Lee MH, Kim SH, Park MJ, Park CK, Rhim H (2011) Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. AJR Am J Roentgenol 197:W868–W875CrossRef
15.
go back to reference Orlacchio A, Chegai F, Fabiano S et al (2016) Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers. Radiol Med 121:588–596CrossRef Orlacchio A, Chegai F, Fabiano S et al (2016) Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers. Radiol Med 121:588–596CrossRef
16.
go back to reference Min JH, Kim YK, Sinn DH et al (2018) Adding ancillary features to enhancement patterns of hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging improves diagnostic performance. Abdom Radiol (NY) 43:2309–2320CrossRef Min JH, Kim YK, Sinn DH et al (2018) Adding ancillary features to enhancement patterns of hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging improves diagnostic performance. Abdom Radiol (NY) 43:2309–2320CrossRef
17.
go back to reference Ronot M, Fouque O, Esvan M, Lebigot J, Aube C, Vilgrain V (2018) Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3cm. J Hepatol 68:715–723CrossRef Ronot M, Fouque O, Esvan M, Lebigot J, Aube C, Vilgrain V (2018) Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3cm. J Hepatol 68:715–723CrossRef
18.
go back to reference Kim YY, An C, Kim S, Kim MJ (2018) Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI. Eur Radiol 28:2038–2046CrossRef Kim YY, An C, Kim S, Kim MJ (2018) Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI. Eur Radiol 28:2038–2046CrossRef
19.
go back to reference Min JH, Kim JM, Kim YK et al (2018) Prospective intraindividual comparison of magnetic resonance imaging with gadoxetic acid and extracellular contrast for diagnosis of hepatocellular carcinomas using the Liver Imaging Reporting and Data System. Hepatology 68:2254–2266CrossRef Min JH, Kim JM, Kim YK et al (2018) Prospective intraindividual comparison of magnetic resonance imaging with gadoxetic acid and extracellular contrast for diagnosis of hepatocellular carcinomas using the Liver Imaging Reporting and Data System. Hepatology 68:2254–2266CrossRef
20.
go back to reference Joo I, Lee JM, Lee DH, Jeon JH, Han JK (2019) Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features? Eur Radiol 29:1724–1732CrossRef Joo I, Lee JM, Lee DH, Jeon JH, Han JK (2019) Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features? Eur Radiol 29:1724–1732CrossRef
Metadata
Title
Ancillary features in the Liver Imaging Reporting and Data System: how to improve diagnosis of hepatocellular carcinoma ≤ 3 cm on magnetic resonance imaging
Authors
Ji Hun Kang
Sang Hyun Choi
Jae Ho Byun
Dong Hwan Kim
So Jung Lee
So Yeon Kim
Hyung Jin Won
Yong Moon Shin
Pyo-Nyun Kim
Publication date
01-05-2020
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 5/2020
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06645-3

Other articles of this Issue 5/2020

European Radiology 5/2020 Go to the issue